NovaBay Pharmaceuticals, Inc.
| NYSE MKT: NBY
NovaBay Pharmaceuticals, Inc. is a clinical stage biotechnology company developing an anti-infective platform of compounds called the Aganocide compounds, for the treatment or prevention of infections in hospital and non-hospital environments. The company operates through four business units: Dermatology, Opthalmology, Urology and Wound Care. It was formerly known as NovaCal Pharmaceuticals, Inc. NovaBay Pharmaceuticals was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.